The National Superintendence of Health sanctioned two pharmaceutical managers for not fulfilling their duties with the affiliates to the system. The companies to which the sumiprocess fines and Audifarma were applied.
(Read more: Economy and politics concern eight out of 10 Colombians starting 2025)
In the case of the latter, the determination of the Supersalud occurs after the pharmacist warned that new EPS has not fulfilled the commitments agreed to continue with the dispensing of medications. Likewise, he pointed out that the lack of payment by this health provider It could jeopardize the timely and effective access of the population to these services.
According to the control entity, both Audifarma and Sumiprocess “They acted irregularly in the dispensation of medicines and/or medical devices, and refused to report relevant information to determine the impact of their breach.”
(Read more: Colombia, among countries with the highest extreme poverty index in South America)
Audifarma
(See: Bogotá goes after more than 1,500 delinquent who hung up with the ICA payment)
What did the Supersalud find?
Punctually, the Superintendency found deficiencies in the information reports delivered Audifarma, as well as a repeated breach in the dispensation of outpatient medicines In the department of Caldas.
In that context, the control body explained that, considering the effects that these actions have on users, a fine equivalent to 230 current monthly minimum wages in force (SMMLV) through an administrative measure.
With regard to somsiprocesses, he stressed that after an audit a series of irregularities was detected in “The delivery of medical devices, not delivery of the required information and not subscription of the improvement plan that, by legal provision, must submit to correct evidence.” In this case, a penalty of 250 SMMLV was established.
The entity also recalled that, at the time, this pharmaceutical manager had signed a contract with an indigenous EPS to operate in the department of La Guajira. At the time of inspection, It was found that it did not have the minimum inventory of medicines and/or medical devices available In your establishment.
(More news: Constitutional Court Tomb Law that allowed child marriage)
Medications
(See: only 4% of cases of fatal traffic accidents come to trial)
Supersalud figures show that 290,836 claims were recorded in the last yearof which 18% were related to the negation or late delivery of medicines and medical devices. This high number of complaints motivated the decision to impose sanctions on these pharmaceutical managers, who have the contractual responsibility to dispense health technologies to the affiliates of the EPS.
In that same line, the entity explained that, by normative provision, currently the control measures that pharmaceutical managers can be imposed are limited to a sanctioning administrative process.
(More news: All real estate investors plan to make new investments in 2025)
Portfolio
